Lazerib 80 mg | Nasima Pharma
WORLDWIDE DOORSTEP DELIVERY

Home Medicines Lazerib 80 mg

Buy Lazerib 80 mg - Lazeritinib Mesylate Hydrate INN Online
Gallery Image
Gallery Image

Scan to Connect

WhatsApp Support QR

WhatsApp

WeChat Support QR

WeChat

Lazerib 80 mg

| In Stock

Generic Name

Lazeritinib Mesylate Hydrate INN

Manufacturer

Everest Pharmaceuticals Ltd.

Pack Size

90's

Shelf Life

24 Months

Category

Anti-Cancer

Price on Request Wholesale

Prices vary by country and quantity. Contact us for a quote.

Description

🟩 Lazerib 80 mg

Generic Name: Lazeritinib Mesylate Hydrate INN
Brand Name: Lazerib
Manufacturer: Everest Pharmaceuticals Ltd.
Strength & Form: 80 mg | Film-coated tablets
Pack Size: 90 tablets


📌 Indications:

Lazerib (Lazeritinib) is indicated for the treatment of patients with non-small cell lung cancer (NSCLC) that is:

  • Locally advanced or metastatic

  • Harboring epidermal growth factor receptor (EGFR) mutations

  • Especially effective in patients who have developed resistance to previous EGFR-targeted therapies.


💊 Pharmacology:

  • Lazeritinib is a third-generation EGFR tyrosine kinase inhibitor (TKI).

  • It selectively inhibits both EGFR sensitizing mutations and the T790M resistance mutation, which is the most common cause of acquired resistance to first/second generation TKIs.

  • It helps block cancer cell proliferation and promotes apoptosis in tumor cells.

  • Lazerib also shows good blood-brain barrier penetration, making it effective against CNS metastases.


💉 Dosage & Administration:

  • Recommended dose: 80 mg once daily, orally.

  • Can be taken with or without food.

  • Treatment should be continued until disease progression or unacceptable toxicity.

⚠️ Tablets should be swallowed whole — not crushed or chewed.


⚠️ Precautions & Warnings:

  • Monitor for interstitial lung disease (ILD)/pneumonitis.

  • Risk of QT prolongation – ECG monitoring may be required.

  • Regular liver function tests recommended.

  • Dose adjustments may be necessary in case of toxicity.


❌ Contraindications:

  • Hypersensitivity to Lazeritinib or any excipients.

  • Not recommended in severe hepatic impairment without careful monitoring.


🤰 Pregnancy & Lactation:

  • May cause fetal harm if administered during pregnancy.

  • Women of childbearing potential should use effective contraception.

  • Not recommended during breastfeeding.


⚕️ Side Effects:

Common:

  • Rash, diarrhea, nausea, stomatitis

  • Decreased appetite

  • Fatigue

  • Dry skin and pruritus

Serious:

  • Interstitial lung disease/pneumonitis

  • QT prolongation and cardiac arrhythmia

  • Severe hepatotoxicity


🧊 Storage Conditions:

  • Store below 30°C, in a dry place.

  • Protect from light and moisture.

  • Keep out of reach of children.

Similar Medicines

Contact Support